Description

Creating a New Class of Drugs to Address Incurable Autoimmune DiseasesEntelexo is creating modern treatments for immune-mediated diseases, such as psoriasis, using novel engineered exosome technology.

 


ACTIVE FOUNDERS

Founder 1

MILAD RIAZIFAR,

Dr. Riazifar has worked on stem cells over a decade and on exosomes a subclass of stem cell derived extracellular vesicles since 2012. During his Ph.D studies at the Stem Cell Research Center at the University of California Irvine, he pioneered a cell-free exosome-based approach to treat Multiple Sclerosis. At City of Hope, he was part of a clinical translation team initiating the world’s first clinical trial using stem cell exosomes for the treatment of type I diabetes.

Twitter: | Linkedin: https://www.linkedin.com/in/miladriazifar/


Founder 2

Todd Schurr,

Multidisciplinary engineer with diverse experience in cellular biology, electrical engineering, automotive, and more. To quote Einstein, I am "passionately curious" about just about everything.

Twitter: | Linkedin: https://www.linkedin.com/in/todd-schurr/


Founder 3

Cameron Taylor,

MSE in Biomedical Engineering from University of Michigan, Class of 2018 Co-Founder and CTO at Entelexo Biotherapeutics.

Twitter: | Linkedin: https://www.linkedin.com/in/cameron-taylor-448b5a130/


Founder 4

,

Twitter: | Linkedin:


Founder 5

,

Twitter: | Linkedin:


Founder 6

,

Twitter: | Linkedin:

Based in
Nation
Founded in

2020

Team Size

3

Not Available
Today's work schedule is not available
  • Monday

    By appointment only

  • Tuesday

    N/A

  • Wednesday

    N/A

  • Thursday

    N/A

  • Friday

    N/A

  • Saturday

    N/A

  • Sunday

    N/A

  • 4 October 2022 2:26 local time

Follow us
mood_bad
  • No comments yet.
  • Add a review
      error: Content protected